Overview

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the response of patients with hypertension and early stage heart failure to valsartan.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Valsartan